Two problems in antisense biotechnology: in vitro delivery and the design of antisense experiments

被引:75
作者
Stein, CA
机构
[1] Columbia Univ, Dept Med, New York, NY 10032 USA
[2] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION | 1999年 / 1489卷 / 01期
关键词
antisense oligonucleotide; internalization; delivery; data interpretation; design of antisense experiments;
D O I
10.1016/S0167-4781(99)00143-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Antisense oligonucleotides are invaluable reagents for the specific downregulation of gene expression. In the absence of a carrier, charged oligonucleotides (e.g., phosphorothioates) can interact with a large number of cell surface proteins, but tend to be internalized into the endosomal/lysosomal compartment. However, they can be successfully delivered to the nuclei of diverse cell types via the use of a wide variety of reagents, including cationic lipids, and cationic polyamines. Over the past several years, a more general understanding of the rules governing the interpretation of data derived from antisense experiments has been reached. These are discussed with emphasis on how to avoid some of the confounding features of this important, emerging technology. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:45 / 52
页数:8
相关论文
共 52 条
[1]   AN OLIGOMER COMPLEMENTARY TO C-MYB-ENCODED MESSENGER-RNA INHIBITS PROLIFERATION OF HUMAN MYELOID-LEUKEMIA CELL-LINES [J].
ANFOSSI, G ;
GEWIRTZ, AM ;
CALABRETTA, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (09) :3379-3383
[2]   BINDING, UPTAKE, AND INTRACELLULAR TRAFFICKING OF PHOSPHOROTHIOATE-MODIFIED OLIGODEOXYNUCLEOTIDES [J].
BELTINGER, C ;
SARAGOVI, HU ;
SMITH, RM ;
LESAUTEUR, L ;
SHAH, N ;
DEDIONISIO, L ;
CHRISTENSEN, L ;
RAIBLE, A ;
JARETT, L ;
GEWIRTZ, AM .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (04) :1814-1823
[3]   Cationic porphyrins: novel delivery vehicles for antisense oligodeoxynucleotides [J].
Benimetskaya, L ;
Takle, GB ;
Vilenchik, M ;
Lebedeva, I ;
Miller, P ;
Stein, CA .
NUCLEIC ACIDS RESEARCH, 1998, 26 (23) :5310-5317
[4]   Formation of a G-tetrad and higher order structures correlates with biological activity of the ReIA (NF-kappa B p65) 'antisense' oligodeoxynucleotide [J].
Benimetskaya, L ;
Berton, M ;
Kolbanovsky, A ;
Benimetsky, S ;
Stein, CA .
NUCLEIC ACIDS RESEARCH, 1997, 25 (13) :2648-2656
[5]   BINDING OF PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES TO BASIC FIBROBLAST GROWTH-FACTOR, RECOMBINANT SOLUBLE CD4, LAMININ AND FIBRONECTIN IS P-CHIRALITY INDEPENDENT [J].
BENIMETSKAYA, L ;
TONKINSON, JL ;
KOZIOLKIEWICZ, M ;
KARWOWSKI, B ;
GUGA, P ;
ZELTSER, R ;
STEC, W ;
STEIN, CA .
NUCLEIC ACIDS RESEARCH, 1995, 23 (21) :4239-4245
[6]   Mac-1 (CDllb/CD18) is an oligodeoxynucleotide-binding protein [J].
Benimetskaya, L ;
Loike, JD ;
Khaled, Z ;
Loike, G ;
Silverstein, SC ;
Cao, L ;
Khoury, JE ;
Cai, TQ ;
Stein, CA .
NATURE MEDICINE, 1997, 3 (04) :414-420
[7]  
Bennett CF, 1998, APPLIED ANTISENSE OLIGONUCLEOTIDE TECHNOLOGY, P129
[8]  
BENNETT CF, 1992, MOL PHARMACOL, V41, P1023
[9]  
Bennett CF, 1993, J LIPOSOME RES, V3, P85
[10]   DNA-BINDING TO HUMAN-LEUKOCYTES - EVIDENCE FOR A RECEPTOR-MEDIATED ASSOCIATION, INTERNALIZATION, AND DEGRADATION OF DNA [J].
BENNETT, RM ;
GABOR, GT ;
MERRITT, MM .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (06) :2182-2190